Expanding Manufacturing Capabilities Novasep has recently invested heavily in expanding its production capacity and upgrading key manufacturing sites in France, including assets worth over EUR 11 million. This opens opportunities for sales of advanced process equipment, turnkey solutions, and capacity-building services to support their growth in high potency APIs and complex small molecules.

Strategic Industry Partnerships The company has established collaborations with notable biotech and pharmaceutical firms such as Exelixis and Pfizer, focusing on high-value projects like antibody-drug conjugates and COVID-19 treatments. This presents potential avenues for offering specialized technologies, contract manufacturing, and R&D services aligned with their strategic alliance needs.

Focus on High-Tech Solutions Novasep’s expertise in innovative technologies including chromatography, hazardous chemistry, and cryogenic processes positions them as a key partner for clients seeking sophisticated purification and manufacturing solutions for complex molecules, enabling opportunities to promote advanced equipment and process integration services.

Global R&D Reach With research labs and pilot plants across Europe, North America, and Asia, Novasep is well-positioned to support international clients and expand its service offerings globally. Sales efforts can target multinational pharma and biotech companies looking for localized and scalable production and development collaborations.